Paper: J Vet Res
68, 2024 & Polish Journal of Veterinary Sciences Vol. 27, No. 2
(2024), 165–
See
the attached documents for the summary and click
here for the full paper of J Vet Res 68, 2024 and Polish Journal of Veterinary Sciences Vol. 27, No. 2 (2024), 165– (open access).
Two studies focused on monitoring
vector-borne diseases in anemic dogs arriving in or returning to Poland from
endemic regions, comparing results obtained using Vcheck M Canine Vector 8
(CV8) with those from real-time or conventional PCR.
According to the first study, molecular tests identified vector-borne pathogens in 79 dogs. All positive results from Vcheck M CV8 were validated by standard real-time PCR with no false positives detected. Therefore, the Vcheck M CV8 provides comparable results to real-time PCR. Its capability for onsite testing is crucial for promptly detecting infections and initiating timely therapy, thereby reducing the time needed for laboratory confirmation.
The second study aimed to detect Hepatozoon canis from dogs suspected of tick-borne diseases, shedding light on prevalence and clinical implications in Poland. Despite sporadic H. canis cases and infrequent R. sanguineus ticks, the study highlighted the necessity of considering H. canis in diagnosing vector-borne diseases, especially in anemic dogs in Poland. The study underscored the importance of comprehensive screening, such as with Vcheck M CV8, in identifying diverse threats, particularly amid increased travel and climate change which may introduce novel pathogens.
The Vcheck M CV8 Panel is point-of-care(POC) molecular diagnostic cartridge designed for simultaneous detection of Canine Vector-borne Disease 8 pathogens: Leishmania spp., Babesia spp., Mycoplasma haemocanis, Hepatozoon spp., Ehrlichia spp., Anaplasma spp., Rickettsia rickettsii, and Bartonella spp. in canine whole blood. Learn more